Otsuka Pharmaceutical.

No events began in the chosen period. Widen it, or reset.

• FDA Structural
  HHS policy allows peptides in compounding pharmacies despite FDA lack of approval, with RFK Jr. arguing for safer compounds.
  Moves Otsuka Pharmaceutical

  21:18
• Sto Transactional
  A company involving Sto seeks delisting from Nasdaq First North Growth Market for financing while developing Tumorad for cancer treatment.
  Moves Otsuka Pharmaceutical

  Thu 19:37

• FDA Structural

  Otsuka Pharmaceutical is seeking market approval from the FDA for its product centanafadine.

  Some supportJul 14
  Otsuka Pharmaceutical → FDA

  FDA → Otsuka Pharmaceutical
• Sto Transactional

  Otsuka Pharmaceutical provides financial funding for clinical studies related to Sto's research.

  Some supportOct 20
  Otsuka Pharmaceutical → Sto

  Sto → Otsuka Pharmaceutical